Ensus UK Limited

Manufacture of other organic basic chemicals · Redcar

ActiveUnited KingdomIncorporated 2006Private Limited Company

Financial position

Accounts to 2026-02-28 · GBP · Company accounts

Net assets

−£12,626,000

Cash

£2,919,000

Turnover

£89,020,000

Profit / loss

−£10,334,000

Current assets

£17,487,000

Creditors < 1 year

£6,891,000

Equity

−£12,626,000

Average employees

Not available

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

2 periods

Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts

Reported figures	2026-02-2812 months · Company · AI-read	2025-02-2812 months · Company · AI-read
Balance sheet
Net assets	−£12,626,000	−£1,793,000
Equity	−£12,626,000	−£1,793,000
Share capital	£5,015,000	£5,015,000
Retained earnings	−£87,633,000	−£77,299,000
Assets
Current assets	£17,487,000	£51,370,000
Cash at bank	£2,919,000	£8,137,000
Debtors	£8,389,000	£27,080,000
Stock	£6,179,000	£16,153,000
Liabilities
Creditors	£30,113,000	£53,163,000
Creditors within one year	£6,891,000	£52,279,000
Creditors after one year	£23,222,000	£884,000
Capital commitments	£3,491,000	£4,276,000
Net current assets	£10,596,000	−£909,000
Assets less current liabilities	£10,596,000	−£909,000
Profit & loss
Turnover	£89,020,000	£188,853,000
Cost of sales	−£104,046,000	−£224,117,000
Gross profit	−£15,026,000	−£35,264,000
Distribution costs	−£2,036,000	−£2,352,000
Administrative expenses	−£3,321,000	−£3,118,000
Other operating income	£7,760,000	−£1,232,000
Operating profit	−£13,223,000	−£150,025,000
Interest payable	−£2,739,000	−£14,000
Profit before tax	−£15,962,000	−£150,039,000
Tax	−£5,628,000	−£6,898,000
Profit / loss	−£10,334,000	−£143,141,000
Operating costs
Research & development	—	£734,000
Government grants	£9,412,000,000	—
People & pay
Staff costs	£6,916,000	£7,442,000
Source evidence	View filing	View filing

From the accounts

What the accounts for 2026-02-28 say about themselves, read by AI from the scanned filing.

Going concern: The auditor reported a material uncertainty about going concern
Principal activity: The principal activity of the company is the operation of a biorefinery to manufacture and sell bioethanol to the European transport fuels sector and protein concentrate to the animal feed market and Biogenic CO2 to food and industrial applications.
What it does: biorefinery · bioethanol · transport fuels · protein concentrate · animal feed · Biogenic CO2 · food and industrial applications (AI keywords)
The year: Key financial KPI’s include, EBITDA excluding impairment, calculated as operating loss adding back depreciation £12,623,000 (2025: loss £31,982,000) and EBIT excluding impairment calculated as operating loss before interest and tax £12,629,000 (2025: loss £41,966,000). Other measures for the business include occupational and process safety, plant reliability, output rates and operating efficiencies.
Outlook: A deal was finalised and announced in March 2026 and the business restarted production of Ethanol, animal proteins and CO2 shortly afterwards. This package of support is expected to be in place until long term structural changes to the ethanol market can be introduced and which would allow the business to operate without Government support.
Auditor: KPMG LLP · senior statutory auditor Oliver Stephenson
Audit opinion: Clean (unmodified)
Immediate parent: CropEnergies Beteiligungs GmbH · Germany
Accounts: Full accounts · FRS 101
Approved: 2026-08-20, signed by M Conway

Turnover by segment (10)

Revenue ethanol: 69,702 (000s) (2026-02-28)
Revenue DDGS: 17,564 (000s) (2026-02-28)
Revenue CO2: 754 (000s) (2026-02-28)
Other miscellaneous (including Syrup): 1,000 (000s) (2026-02-28)
Revenue ethanol: 144,994 (000s) (2025-02-28)
Revenue DDGS: 39,761 (000s) (2025-02-28)
Revenue CO2: 2,016 (000s) (2025-02-28)
Other miscellaneous (including Syrup): 2,082 (000s) (2025-02-28)
UK: 89,020 (000s) (2026-02-28)
UK: 188,853 (000s) (2025-02-28)

Directors' report (8)

Sir R J Margetts
G Pearson
Dr. U P Boltersdorf
Dr F G von Graevenitz
H Baumbach
M Conway
D Waugh
M Price

Share classes (1)

5,015,002 Ordinary Shares of £1.00 each of £1.00

Principal risks (3)

Plant output
External market uncertainties
Seasonality and pricing risk

Events after the year end (1)

In March 2026, the UK Government decided to provide substantial financial support to Ensus UK Ltd. The UK Government has agreed a funding package to keep the plant in a ready to operate standby mode, the plant had suspended production in September 2025 due to economic pressures. With effect from March 2026, production at the plant is being restarted as part of the government support package.